Azide as a probe of proton transfer reactions in photosynthetic oxygen evolution.
In oxygenic photosynthesis, photosystem II (PSII) is the multisubunit membrane protein responsible for the oxidation of water to O2 and the reduction of plastoquinone to plastoquinol. One electron charge separation in the PSII reaction center is coupled to sequential oxidation reactions at the oxygen-evolving complex (OEC), which is composed of four manganese ions and one calcium ion. The sequentially oxidized forms of the OEC are referred to as the S(n) states. S(1) is the dark-adapted state of the OEC. Flash-induced oxygen production oscillates with period four and occurs during the S(3) to S(0) transition. Chloride plays an important, but poorly understood role in photosynthetic water oxidation. Chloride removal is known to block manganese oxidation during the S(2) to S(3) transition. In this work, we have used azide as a probe of proton transfer reactions in PSII. PSII was sulfate-treated to deplete chloride and then treated with azide. Steady state oxygen evolution measurements demonstrate that azide inhibits oxygen evolution in a chloride-dependent manner and that azide is a mixed or noncompetitive inhibitor. This result is consistent with two azide binding sites, one at which azide competes with chloride and one at which azide and chloride do not compete. At pH 7.5, the K(i) for the competing site was estimated as 1 mM, and the K(i)' for the uncompetitive site was estimated as 8 mM. Vibrational spectroscopy was then used to monitor perturbations in the frequency and amplitude of the azide antisymmetric stretching band. These changes were induced by laser-induced charge separation in the PSII reaction center. The results suggest that azide is involved in proton transfer reactions, which occur before manganese oxidation, on the donor side of chloride-depleted PSII.
Cooper
Ian B
IB
School of Chemistry and Biochemistry and the Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
Barry
Bridgette A
BA
D001386:Azides / Q000378:metabolism / Q000494:pharmacology*; D002712:Chlorides / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology; D006860:Hydrogen Bonding; D008027:Light; D010084:Oxidation-Reduction / Q000187:drug effects; D010100:Oxygen / Q000378:metabolism*; D010788:Photosynthesis / Q000187:drug effects*; D045332:Photosystem II Protein Complex / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism*; D011522:Protons; D017550:Spectroscopy, Fourier Transform Infrared; D013057:Spectrum Analysis; D018724:Spinacia oleracea / Q000201:enzymology*; D013431:Sulfates / Q000378:metabolism; D014732:Vibration
D001386:Azides; D002712:Chlorides; D004791:Enzyme Inhibitors; D045332:Photosystem II Protein Complex; D011522:Protons; D013431:Sulfates; D010100:Oxygen